Logo image
Engineering Protein Delivery Depots for Cancer Immunotherapy
Journal article   Peer reviewed

Engineering Protein Delivery Depots for Cancer Immunotherapy

Di Wen, Guojun Chen, Qian Chen, Peter Y. Li, Hao Cheng and Zhen Gu
Bioconjugate chemistry, v 30(3), pp 515-524
01 Mar 2019
PMID: 30839198

Abstract

Biochemical Research Methods Biochemistry & Molecular Biology Chemistry Chemistry, Multidisciplinary Chemistry, Organic Life Sciences & Biomedicine Science & Technology Physical Sciences
Cancer immunotherapy that induces a tumor-specific immune response for cancer eradication has received tremendous attention. To enhance the immunotherapeutic effects, many drug delivery strategies have been developed to overcome the physiological barriers as well as to reduce toxicity. For example, intratumoral or peritumoral administration of injectable depot formulations can directly target tumor sites for immunotherapy. Compared with systemic administration of therapeutics, this strategy has minimal side effects. Such local treatment can also trigger a systemic immune response for inhibiting tumor metastasis. This Topical Review highlights the recent studies on depot-mediated delivery of protein/peptide therapeutics for cancer immunotherapy. Further opportunities and challenges in this field are also discussed.

Metrics

5 Record Views
24 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biochemical Research Methods
Biochemistry & Molecular Biology
Chemistry, Multidisciplinary
Chemistry, Organic
Logo image